Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics is a research paper published in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P30CA33572
US Department of Defense
Grant: W81XWH-22-1-0331
US Department of Defense
Grant: HT9425-25-1-0500
US Department of Defense
Grant: W81XWH-16-1-0641
Beckman Research Institute, City of Hope
National Cancer Institute
MeSH Terms
Keywords